Table 2.
Patients’ medical and medication histories (N = 162 for anemic patients, N = 295 for non-anemic patients)
| Parameters | Number (%) | |
|---|---|---|
| Anemic patients | Non-anemic patients | |
| Medical conditions | ||
| Dyslipidemia | 150 (92.6) | 274 (92.9) |
| Hypertension | 149 (92) | 259 (87.8) |
| Hematological disorders | 146 (90.1) | 55 (18.6) |
| Diabetes mellitus | 112 (69.1) | 183 (62) |
| Other cardiovascular disease | 75 (46.3) | 99 (33.6) |
| Ischemic heart disease | 67 (41.4) | 116 (39.3) |
| Cerebrovascular accident | 47 (29) | 51 (17.3) |
| Respiratory disorders | 43 (26.5) | 19 (6.4) |
| Heart failure | 35 (21.6) | 54 (18.3) |
| Gastrointestinal disorders | 19 (11.7) | 36 (12.2) |
| Endocrine disorders | 5 (3.1) | 15 (5.1) |
| Oncologic disorders | 3 (1.9) | 13 (4.4) |
| Immunological disorders | 3 (1.9) | 12 (4.1) |
| Medications | ||
| Iron supplements | 69 (42.6) | 78 (26.4) |
| Angiotensin receptor blockers | 59 (36.4) | 135 (45.8) |
| Angiotensin-converting-enzyme inhibitors | 38 (23.5) | 107 (36.3) |
| Renalmin/Revalvite | 33 (20.4) | 44 (14.9) |
| Vitamin B12 supplements | 30 (18.5) | 31 (10.5) |
| Immunosuppressants | 8 (4.9) | 20 (6.8) |
| Fibric acid derivatives | 5 (3.1) | 22 (7.5) |
| Folate supplements | 13 (8) | 10 (3.4) |